SPL 1.60% 9.6¢ starpharma holdings limited

ASCO Presentations 2024

  1. 12,865 Posts.
    lightbulb Created with Sketch. 1414







    2024 ASCO Annual Meeting


    2024 ASCO Annual Meeting
    Oral Abstract Session

    Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology

    Primary Track: Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
    June 1 – 3:00 PM CDT
    location_onHall D1




    2024 ASCO Annual Meeting
    Rapid Oral Abstract Session

    Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology

    Primary Track: Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
    June 3 – 8:00 AM CDT
    location_onS406
    Dendrimer-enhanced (DEP) SN38 (DEP irinotecan) in patients (pts) with advanced solid tumors: A phase 1/2 trial.

    8:12 AM CDTJia (Jenny) Liu, MD, PhDAbstract 3014
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.6¢
Change
0.002(1.60%)
Mkt cap ! $39.38M
Open High Low Value Volume
9.4¢ 9.6¢ 9.4¢ $32.09K 339.3K

Buyers (Bids)

No. Vol. Price($)
1 3699 9.5¢
 

Sellers (Offers)

Price($) Vol. No.
9.8¢ 65000 1
View Market Depth
Last trade - 13.54pm 06/08/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.